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Abstract 
Aim of the study. To evaluate in an established porcine post cardiac arrest model the effect of a mild 
hypercapnic ventilatory strategy on outcome. 
Methods. The left anterior descending coronary artery was occluded in 14 pigs and ventricular 
fibrillation induced and left untreated for 12 min. Cardiopulmonary resuscitation was performed for 
5 min prior to defibrillation. After resuscitation, pigs were assigned to either normocapnic (end-tidal 
carbon dioxide (EtCO2) target: 35-40 mmHg) or hypercapnic ventilation (EtCO2 45-50 mmHg). 
Hemodynamics was invasively measured and EtCO2 was monitored with an infrared capnometer. 
Blood gas analysis, serum neuron-specific enolase (NSE) and high sensitive cardiac troponin T (hs-
cTnT) were assessed. Survival and functional recovery were evaluated up to 96 h.  
Results. Twelve pigs were successfully resuscitated and eight survived up to 96 h, with animals in 
the hypercapnic group showing trend towards a longer survival. EtCO2 and arterial partial pressure 
of CO2 were higher in the hypercapnic group compared to the normocapnic one (p<0.01), during the 
4-hour intervention. Hypercapnia was associated with higher mean arterial pressure compared to 
normocapnia (p<0.05). No significant differences were observed in hs-cTnT and in NSE between 
groups, although the values tended to be lower in the hypercapnic one. Neuronal degeneration was 
lesser in the frontal cortex of hypercapnic animals compared to the normocapnic ones (p<0.05). 
Neurological recovery was equivalent in the two groups. 
Conclusion. Mild hypercapnia after resuscitation was associated with better arterial pressure and 
lesser neuronal degeneration in this model. Nevertheless, no corresponding improvements in 
neurological recovery were observed.  
 
Protocol no. 84/2014-PR 
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Introduction 
Despite of continuous improvements in post-resuscitation (PR) care, outcome of cardiac arrest (CA) 
remains poor. Indeed, more than half of resuscitated patients die early after hospital admission,[1,2] 
such that the final survival ranges from 0.5 to 20% in Europe, with great differences among 
countries.[3,4] For this reason, one of the main objective of resuscitation science is investigating 
novel therapeutic strategies that may improve survival with good neurological recovery.[5,6] For 
example, the optimal respiratory targets, i.e. ideal blood partial pressure (Pa) of oxygen (O2) and 
carbon dioxide (CO2) are currently unknown and several specific trials have been undertaken.[7-9]  
 Recently, the role of PaCO2 became of particular interest after the publication of a series of 
experimental and observational studies anticipating potential benefits on CA outcome from a 
ventilation pattern set to maintain a mild hypercapnia.[8,10,11] In a rodent model of global cerebral 
ischemia but without cardiac arrest, mild to moderate hypercapnia (PaCO2 60–100 mmHg) was 
associated with lesser histological brain damage and lesser apoptosis compared to normocapnia or 
severe hypercapnia after cerebral ischemia.[12] Pathophysiologically, hypercapnia holds interesting 
properties that might be beneficial for CA patients such as an increase in cerebral blood flow, an 
increase in arterial blood pressure due to endogenous catecholamine release, and an attenuation of 
ischemia-reperfusion injury due to mitigation of oxidative stress.[13-15]  
This study aimed to investigate the effects of PR mild hypercapnia on survival and functional 
recovery in a porcine post-CA model. We hypothesized that a period of hypercapnia after 
resuscitation might ameliorate cardiac and neurological dysfunction and survival compared to 
normocapnia. 
 
Material and methods 
All procedures involving animals and their care were in conformity with national and international 
laws and policies. Approval of the study was obtained by the governmental review board, within a 
wider protocol on inhalatory strategies to improve CA outcome (N.84/2014-PR). 
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Animal Preparation 
Fourteen male domestic pigs (38±3 kg) were fasted the night before experiment except for free water 
access. Anaesthesia was induced by intramuscular injection of ketamine (20 mg/kg) followed by 
intravenous administration of propofol (2 mg/kg) and sufentanyl (0.3 μg/kg) through an ear vein 
access. Anaesthesia was then maintained by continuous intravenous infusion of propofol (4-8 
mg/kg/h) and sufentanyl (0.3 μg/kg/h). Intravenous cis-atracurim (0.5 mg/kg) was administered at 
hourly interval for muscle relaxation. A cuffed tracheal tube was placed, and animals were 
mechanically ventilated with a tidal volume of 15 mL/kg and fraction of inspired oxygen (FiO2) of 
0.21. During the preparation phase, respiratory frequency was adjusted to maintain the end-tidal 
partial pressure of carbon dioxide (EtCO2) between 35-40 mmHg, monitored with an infrared 
capnometer.[16] For measurement of aortic pressure, a fluid-filled 7F catheter was advanced from 
the right femoral artery into the thoracic aorta. For measurements of right atrial pressure (RAP), core 
temperature, and cardiac output (CO), a 7F pentalumen thermodilution catheter was advanced from 
the right femoral vein into the pulmonary artery. Myocardial infarction was induced in a closed-chest 
preparation by intraluminal occlusion of the left anterior descending (LAD) coronary artery with the 
aid of a 6F balloon-tipped catheter inserted from the right common carotid artery.[16] For inducing 
ventricular fibrillation (VF), a 5F pacing catheter was advanced from the right jugular vein into the 
right ventricle. The position of all catheters was confirmed by characteristic pressure morphology 
and/or fluoroscopy. Frontal plane electrocardiogram was recorded.  
 
Experimental procedure 
Fifteen min prior to induce CA, animals were randomized into hypercapnia or normocapnia 
ventilation. The balloon of the LAD coronary artery catheter was then inflated with 0.7 mL of air to 
occlude the flow. If VF did not occur spontaneously, after 10 min it was induced with 1-2 mA AC 
current delivered to the right ventricle endocardium.[16] Ventilation was discontinued after onset of 
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VF. After 12 min of untreated VF, cardiopulmonary resuscitation (CPR), including chest 
compressions with the LUCAS 2 (PhysioControl Inc.) and ventilation (tidal volume of 500 mL, 10 
breaths/min, FiO2 100%), was initiated. After 5 min of CPR, defibrillation was attempted with a 
single biphasic 150-J shock, using an MRx defibrillator (Philips Medical Systems). If resuscitation 
was not achieved, CPR was resumed and continued for 1 min prior to a subsequent defibrillation. 
Adrenaline (30 µg/kg) was administered via the right atrium after 2 and 7 min of CPR. Successful 
resuscitation was defined as restoration of an organized cardiac rhythm with a mean arterial pressure 
(MAP) of more than 60 mmHg. After that, if VF reoccurred, it was treated by immediate 
defibrillation. After successful resuscitation, anaesthesia was maintained, and animals were 
monitored during the 4-h treatment.  
Animals were subjected to a 4-h normocapnia or hypercapnia ventilation. For this aim, respiratory 
rate was adjusted while keeping tidal volume constant, in order to obtain an EtCO2 within 35-40 
mmHg in the control normocapnic group or within 45-50 mmHg in the treatment hypercapnic group.  
Forty-five minutes after resuscitation, the LAD coronary artery catheter was withdrawn. Temperature 
of the animals was maintained at 38±0.5°C during the whole experiment. After 4 h of treatment, 
catheters were removed, wounds were repaired, and the animals were extubated and returned to their 
cages. Analgesia with butorphanol (0.1 mg/kg) was administered by intramuscular injection. At the 
end of the 96 h PR period, animals were sedated with  intramuscular ketamine (20 mg/kg ) and 
intravenous propofol  (1 mg/kg bolus, followed by 2-3 mg/kg/h infusion) through an ear vein access 
and maintained spontaneously breathing for echocardiographic examination and blood sample 
withdrawn by direct femoral artery puncture. Animals were then sacrified painlessly with an 
intravenous injection of 150 mg/kg sodium thiopental, and heart and brain were harvested. Autopsy 
was performed routinely for potential injuries due to CPR or obfuscating disease. The experimental 
design is summarized in Figure 1. 
 
Measurements  
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Hemodynamics, EtCO2, and electrocardiogram were recorded continuously on a personal computer-
based acquisition system (WinDaq DATAQ Instruments Inc). The coronary perfusion pressure was 
computed from the differences in time-coincident diastolic aortic pressure and RAP. CO was 
measured by thermodilution technique (COM-2; Baxter International Inc). Transthoracic 
echocardiography was performed using a phase-array multifrequency 2.5-5-MHz probe (CX50, 
Philips, Spa). Two-dimensional apical four chamber view was acquired to determine left ventricular 
(LV) volumes and ejection fraction (EF); calculations were computed using the modified single-plane 
Simpson’s rule.[16] Stroke volume was calculated by applying the formula: CO/heart rate. CO was 
determined as the product of the time-velocity integral of the outflow curves obtained in 5-CH apical 
view using pulsed wave Doppler and the cross sectional area of the aortic anulus obtained from 2D- 
echocardiography image in parasternal long-axis view. Arterial blood gases were assessed with i-
STAT System (Abbott Laboratories). Plasma high-sensitivity cardiac troponin T (hs-cTnT) and 
serum neuron-specific enolase (NSE) were measured with electrochemiluminescence assays (Roche 
Diagnostics Spa). 
 
As previously described,[16] neurologic recovery was assessed with the neurologic alertness score 
(NAS), ranging from 100 (normal) to 0 (brain death), and with the swine neurologic deficit score 
(NDS), ranging from 0 (normal) and 400 (brain death). Finally, the functional recovery was evaluated 
prior to sacrifice according to overall performance categories (OPC), ranging from 1=normal to 
5=brain death or death.[16]  Outcome was defined poor when OPC was ≥3. Scores were assessed by 
veterinary doctors blinded to treatment. 
 
At sacrifice, the brains were carefully removed from the skulls and fixed in 4% buffered formalin. 
Standardized 5-mm coronal slices were taken. The hippocampal CA1 sector and the cortex were 
chosen as regions of interest and were paraffin embedded. Five-micrometer-thick sections were then 
obtained and stained with hematoxylin-eosin. The proportion of neuronal loss and 
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degeneration/necrosis (shrunken neurons with deeply acidophilic cytoplasm and pyknotic nucleus) 
was quantified as absent (0), rare (1), few (2), and numerous (3). For apoptosis, sections were stained 
immunohistochemically with a rabbit polyclonal anti-cleaved caspase-3 primary antibody. For 
evaluation of vascular leakage, as expression of endothelial cell damage in capillary ultrastructure, 
[17] sections were stained with a rabbit polyclonal anti-albumin antibody. Details in Supplementary 
Figure 1. An experienced pathologist, blinded to treatment, performed the assessments. 
 
Myocardial infarct was assessed by tetrazolium chloride (TTC) staining in 5-mm-thick LV transverse 
sections. Infarct size was reported as percentage of TTC-negative area relative to LV area.[16]  
 
Statistical Analysis 
One sample Kolmogorov–Smirnov Z test was used to confirm normal distribution of the data. For 
comparisons of time-based variables, repeated measures analysis of variance (ANOVA) with Holm-
Sidak’s multiple comparison was used. For comparisons between groups at the given time points, 
one-way ANOVA was used for normally distributed variables, while Kruskal-Wallis test with Dunn’s 
multiple comparison was used for not normally distributed variables. When the dependent variable 
was categorical, χ2 test was performed. For survival analysis, Kaplan-Meier survival curves and log-
rank (Mantel-Cox) test were used. Data are expressed as mean ± standard deviation (SD), except for 
hs-cTnT and NSE, presented as median and interquartile range (IQR). The sample size was estimated 
regarding the neurological functional score NAS [5]. To show a NAS recovery in the hypercapnia 
group, i.e. a 45% NAS increase compared to control, 7 pigs per group were needed (β 0.8, α 0.05). A 
p ≤ 0.05 was regarded as statistically significant. Data analyses were performed using GraphPad 
Prism (version 6.05 for Windows, GraphPad Software, USA). 
 
Results 
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No significant differences in body weight, hemodynamics, myocardial function, and blood gas 
analyses were observed between groups at baseline (Table). All the animals, except 2 in the 
hypercapnia group, were successfully resuscitated. The duration of CPR and the total number of 
defibrillation delivered were similar in both groups (Table). Eighty percent of the animals resuscitated 
from CA and treated with hypercapnia survived till 96 h compared to 57% in the normocapnia group 
(Figure 2).  
 
After resuscitation, EtCO2 and PaCO2 were significantly higher in the hypercapnia group compared 
to the normocapnia one, during the 4 h of treatment (Table). Animals in the hypercapnia group 
showed a trend toward a lower arterial pH and PaO2 compared to normocapnia ones, although the 
differences were not significant (Table). The hypercapnia group showed a significantly higher PR 
systolic, mean, and diastolic arterial pressures compared to the normocapina one (p<0.05, Figure 3). 
No effects of hypercapnia on heart rate and RAP were observed (Table). 
 
PR myocardial function was depressed in all animals. No differences in EF and stroke volume, 
between the two groups were observed during the whole period of observation (Table). Hypercapnic 
animals showed a trend toward smaller LV end-diastolic and end-systolic volumes compared to 
hypercapnic ones during the first 4 h of treatment.  
 
No difference in LV infarct size was observed in the two groups (Table) and this result was 
concordant with the plasma levels of hs-cTnT. Only a trend towards a lower hs-cTnT in the 
hypercapnia group was reported at 96 h after resuscitation (56 vs. 153 ng/L, p not significant; Figure 
4). 
 
A good neurological recovery, i.e. OPC 1-2, was observed in 20% of the animals in the hypercapnia 
group and in 29% in the normocapnia one (p not significant, Table). No significant differences were 
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also observed in the NAS and NDS scores in the group treated with hypercapnia compared to 
normocapnia(Figure 5). Overall none or only a few apoptotic neurons and interstitial vascular leakage 
were observed in the cerebral cortex (caspase-3 staining (score): 0.5±0.6 in hypercapnia vs. 0.5±1 in 
control; albumin staining (score): 0.5±0.6 in hypercapnia vs. 0.3±0.5 in control; p not significant) and 
CA1 hippocampal sector (caspase-3: 0.75±0.5 in hypercapnia vs. 0.75±1.5 in control; albumin: 
0.75±0.5 in hypercapnia vs. 0.5±1 in control; p not significant) of all the resuscitated animals. Only 
one animal in the control group showed extensive apoptosis (2+ in cortex and 3+ in CA1) and vascular 
leakage (2+ in cortex) (Supplementary Figure 1). Nevertheless, a significant lesser severe neuronal 
degeneration in the frontal cortex of animals treated with hypercapnia in comparison to those in 
normocapnia was observed (p=0.03, Figure 5). This result was supported by a lower 96 h serum NSE 
concentration in the hypercapnia group (14 vs 21 ng/mL, p not significant; Figure 4). No differences 
in neurological degeneration in the hippocampal CA1 sector were observed.  
 
Discussion 
The present study investigated the effect of post resuscitation mild hypercapnia, obtained by reducing 
minute ventilation, as a potential treatment to improve outcome of CA. Indeed, in our model, a 4-h 
period of mild hypercapnia was associated with a better mean arterial pressure and a decrease in 
neuronal degeneration in the frontal cortex; nevertheless, no corresponding functional improvements 
in neurological recovery were observed.  
 
CO2 is the major determinant of cerebral blood flow, with high PaCO2 causing vasodilatation and 
increased brain perfusion, whereas low PaCO2 induces vasoconstriction and reduced cerebral blood 
flow.[13] It has been suggested that vascular reactivity to CO2 is blunted in the immediate PR period, 
but some evidences suggest that it is preserved after ROSC [18-22]. Thus, mild to moderate 
hypercapnia could alleviate ischemia, especially in the setting of detrimental cerebral 
vasoconstriction, which appears to be the case in post CA patients.[23] Our study confirmed a lesser 
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neuronal injury in the frontal cortex in animals treated with mild hypercapnia, compared to 
normocapnia. We did observe a trend towards lower serum NSE release and frontal lobe neuronal 
injury, however, no differences regarding the degree of neuronal degeneration in hippocampal CA1 
sector and the neurological scores were observed. It is possible that some areas suffered more from 
hypoperfusion and hypoxia despite a global increase in cerebral blood flow and in oxygen delivery.  
Carbon dioxide has also been suggested to exert neuroprotective effects independently of any 
modifications in cerebral perfusion.[12] For example, hypercapnic acidosis may attenuate the 
production of superoxide catalysed by xanthine oxidase, decreasing neuronal oxidative stress.[24] 
Moreover, high level of PaCO2 may reduce the levels of detrimental amino acids like glutamate, thus 
reducing the excitotoxicity induced by high level of excitatory neurotransmitters.[25] We did not 
perform any analysis on molecular pathways of neuronal injury and any possible interaction with 
CO2, so we can only speculate about any direct effect of hypercapnia on neuroprotection.   
 
We observed a consistently higher arterial blood pressure during the 4-h treatment in the hypercapnic 
animals compared to the normocapnic ones. This might have been related to an increase in the 
sympathetic tone due by the release of endogenous catecholamines into the systemic 
circulation.[25,26] This effect might have been, however, counterbalanced by a direct cardiovascular 
depressant effect related to the acidosis with blunting of the catecholamine sensitivity.[27,28] The 
hypercapnia-induced increase in diastolic arterial pressure observed in the current study could have 
theoretically resulted in higher coronary perfusion pressure, but this did not translate into a better 
myocardial function or a decrease in myocardial injury. The slightly lower systemic pH might have 
increased myocardial oxygen consumption due to increases in left and right ventricle afterload and 
therefore blunted any hypercapnia-related beneficial effect.[25,29] 
Hypercapnia may also have deleterious effects such as an increase in intracranial pressure.[30] 
Whether the concomitant increase in MAP results in greater cerebral perfusion pressure maintaining 
adequate global cerebral perfusion pressure is currently unclear.[31,32] In our study we did not 
AC
CE
PT
ED
 M
AN
US
CR
IPT
12 
 
monitor intracranial pressures, so we cannot comment on whether there was any difference in cerebral 
perfusion pressure between groups. Nevertheless, none or only a slight leakage of serum albumin to 
the cerebral interstitial space was observed in hypercapnic animals, thus potentially excluding 
hypercapnia-related development of brain edema.[17] 
In humans, a possible beneficial effect of mild hypercapnia has been shown with data from 
observational studies.[10,11,19] In the only randomized controlled trial, compared to normocapnia 
(35-45 mmHg), mild hypercapnia (50–55 mmHg) was associated with significantly lower NSE, while 
no adverse effects related to higher PaCO2 were reported.[8] A large randomized controlled trial is 
planned on the effect of moderate hypercapnia on neurological outcome after out-of-hospital CA.[33] 
 
We recognize limitations in the interpretations of our findings. Firstly, we only tested two different 
levels of hypercapnia for a period of 4 h and during normothermia. Secondly, we focused on 
neurological functional outcome, yet neglecting underlying potential mechanisms of action of PR 
hypercapnia. The 96-h histopathology was probably a too late assessment to show direct effects of 
hypercapnia on the evolving brain injury. Indeed, since none or only a few apoptotic neurons were 
observed in both groups, it cannot be excluded that neurons had already passed through the execution 
phase of apoptosis. Indeed, experimental models have shown caspase-3 activity to peak within 72 h 
after ischemia, while a marked decrease was observed by 96 h, in favor of severe degenerative 
changes.[34, 35] Thirdly, the direct effects of oxygen on CA outcome were not studied directly in the 
present study; however, oxygen may have influenced the physiological effects of CO2, as previously 
reported.[10,36,37] Indeed, in a prospective observational study hypercapnia was associated with 
good neurological outcome at 12 month after resuscitation and this effect was clearly influenced by 
oxygen blood tension: the combination of moderate hypercapnia and mild hyperoxia was associated 
with improved neurological outcome.[10] In our study we observed a trend towards a lower PaO2 in 
the hypercapnia group, due to the low minute ventilation, which might have aggravated the systemic 
acidosis and hidden potential benefits from hypercapnia.[38] Nevertheless, PaO2 was still in the 
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physiological range, while the hypercapnia-related mild acidosis is known to determine a rightward 
shift of the haemoglobin dissociation curve, facilitating tissue O2 release.[15] Most likely, in our 
model, animals were excessively hypoventilated causing atelectasis, and consequently hypoxemia, as 
also suggested by the high alveolar-arterial PaCO2 difference.[39-40] Thus “therapeutic hypercapnia” 
may require the use of a higher positive end expiratory pressure or a higher fraction of inspired oxygen 
to avoid hypoxaemia. Indeed, the Carbon dioxide, Oxygen, and Mean arterial pressure After Cardiac 
Arrest and REsuscitation (COMACARE) trial (NCT02698917) is ongoing, which assess the 
feasibility of targeting low- or high-normal PaCO2, PaO2, and MAP in PR comatose, mechanically 
ventilated patients, as well as its effect on brain injury markers.  
  
Conclusions 
Our study partially confirmed the hypothesis of a beneficial effects of mild hypercapnia on CA 
outcome with better mean arterial pressure and a lesser neuronal degeneration in the frontal cortex. 
However, no corresponding improvements in neurological recovery or survival was observed. A 
greater acidotic status and a lower PaO2 observed during hypercapnia might have blunted its cardio- 
and neuroprotective effects. 
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Figure legends 
 
Figure 1. Schematic representation of the experimental design. VF, ventricular fibrillation; CPR, 
cardiopulmonary resuscitation; EKG, electrocardiography; EF, ejection fraction; P art, arterial 
pressure; P r.atrium, right atrial pressure; ECHO, echocardiography; LAD, left anterior descendent 
coronay artery; ROSC, return of spontaneous circulation; EtCO2, End-tidal CO2 partial pressure; min, 
minutes; h, hours. 
 
Figure 2. Kaplan–Meier curves of post-resuscitation survival up to 96 h in animals successfully 
resuscitated after CA. Survival comparison was performed by log-rank (Mantel-Cox) test. In brackets, 
the number of animals alive throughout the observational period.  AC
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Figure 3.  Mean arterial pressure (MAP), systolic arterial pressure (SAP) and diastolic arterial 
pressure (DAP) at baseline and during the first 4 h post resuscitation. Data are shown as mean ± SD. 
* p < 0.05, repeated measures ANOVA with Holm-Sidak’s multiple comparison. 
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Figure 4. A. Plasma high sensitive cardiac troponin T (hs-cTnT) at baseline, 2 h, 4 h and 96 h post 
resuscitation. B. Serum neuronal specific enolase (NSE) at baseline and 96 h post resuscitation.  
Data are expressed as median and interquartile range. Kruskal-Wallis test with Dunn’s multiple 
comparison was used to compare the groups. 
 
Figure 5. A. Overall performance category (OPC). χ2 test was used for comparison. Data are 
expressed as individual data point and mean of the group (OPC ≤ 2 was considered as good 
neurological outcome). B. Neuronal degeneration in CA1 hippocampal sector and frontal cortex (one-
way ANOVA). C. Neurologic alertness score (NAS) and D. Neurological deficit score (NDS) 
evaluated in animals successfully resuscitated from cardiac arrest at 24, 48 and 72 h post resuscitation 
(repeated measures ANOVA with Holm-Sidak’s multiple comparison).  
Data are expressed as mean ± SD. * p < 0.05. 
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 Normocapnia 
(n=7) 
Hypercapnia  
(n=7) 
p value 
Successful resuscitation, n/n (%) 7/7 (100) 5/7 (71) 0.13 
Total defibrillations, n 18 ± 18 14 ± 9 0.68 
Duration of CPR, sec 394 ± 189 438 ± 234 0.73 
Survival duration, h 56 ± 50 81 ± 34 0.36 
96 h survival,  n/n (%) 4/7 (57) 4/5 (80) 0.36 
OPC ≤ 2, n/n (%)  2/7 (29) 1/5 (20) 0.79 
Heart Rate, beat/min 
BL 
PR 2h 
PR 4h 
 
103 ± 28 
171 ± 23 
153 ± 43 
 
113 ± 44 
162 ± 51 
177 ± 30 
 
0.65 
0.74 
0.33 
Right Atrial Pressure, mmHg 
BL 
PR 2h 
PR 4h 
 
6 ± 2 
8 ± 2 
8 ± 1 
 
5 ± 2 
6 ± 2 
7 ± 4 
 
0.31 
0.11 
0.78 
End-Tidal CO2, mmHg 
BL 
PR 2h 
PR 4h 
 
37 ± 2 
36 ± 1 
36 ± 2 
 
38 ± 2 
48 ± 1 
48 ± 2 
 
0.27 
< 0.01 
< 0.01 
LV CO, L/min 
BL 
PR 2h 
PR 4h 
 
4.5 ± 0.8 
3.3 ± 0.9 
2.8 ± 0.5 
 
5.0 ± 1.7 
3.9 ± 0.6 
2.7 ± 1.3 
 
0.52 
0.27 
0.87 
Table 1. Resuscitation outcomes, hemodynamics, echocardiographic data and blood, gas analysis 
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LV infarct size area, % 9.0 ± 4.4  6.3 ± 6.5 0.52 
LV end-diastolic volume, ml 
BL 
PR 2h 
PR 4h 
PR 96h 
 
36.6 ± 9.7 
38.0 ± 7.2 
45.8 ± 16.3 
39.4 ± 14.8 
 
30.6 ± 1.8 
30.9 ± 10.1 
28.1 ± 9.0 
41.6 ± 10.1 
 
0.209 
0.290 
0.105 
0.840 
LV end-systolic volume, ml 
BL 
PR 2h 
PR 4h 
PR 96h 
 
8.5 ± 3.1 
24.0 ± 6.3 
28.5 ± 12.0 
14.0 ± 4.2 
 
10.5 ± 2.8 
19.4 ± 7.4 
14.8 ± 8.9 
21.2 ± 11.6 
 
0.360 
0.382 
0.117 
0.291 
LV ejection fraction, % 
BL 
PR 2h 
PR 4h 
PR 96h 
 
75.9 ± 8.7 
36.9 ± 8.3 
39.3 ± 9.2 
62.5 ± 6.6 
 
65.5 ± 7.6 
37.9 ± 7.6 
51.2 ± 15.5 
49.0 ± 15.5 
 
0.100 
0.872 
0.236 
0.160 
LV stroke volume, ml 
BL 
PR 2h 
PR 4h 
PR 96h 
 
42.2 ± 15.1 
22.4 ± 4.1 
22.2 ± 3.4 
34.4 ± 3.6 
 
50.4 ± 6.2 
21.6 ± 4.1 
23.1 ± 9.8 
36.4 ± 11.5 
 
0.307 
0.788 
0.883 
0.828 
pH 
    BL 
    PR 2h 
    PR 4h 
 
7.48 ± 0.08 
7.34 ± 0.07 
7.40 ± 0.08 
 
7.46 ± 0.06 
7.23 ± 0.10 
7.27 ± 0.11 
 
0.61 
0.09 
0.07 
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For comparisons of resuscitation and survival outcomes, including OPC, χ2 test was used. One-way 
ANOVA was used for comparisons of number of defibrillation, duration of survival, and LV infarct 
size. For comparisons of all other time-based variables, repeated measures ANOVA with Holm-
Sidak’s multiple comparison was used. 
 
    
PaO2, mmHg 
BL 
PR 2h 
PR 4h 
 
76 ± 16 
111 ± 19 
103 ± 28 
 
81 ± 9 
85 ± 24 
95 ± 21 
 
0.46 
0.09 
0.62 
PaCO2, mmHg 
BL 
PR2h 
PR4h 
 
38 ± 2 
40 ± 2 
41 ± 1 
 
38 ± 3 
54 ± 6 
53 ± 7 
 
0.60 
< 0.01 
< 0.01 
HCO3, mmol/L 
BL 
PR2h 
PR4h 
 
29 ± 5 
22 ± 4 
25 ± 4 
 
28 ± 2 
23 ± 3 
27 ± 5 
 
0.64 
0.72 
0.65 
BE, mmol/L 
BL 
PR2h 
PR4h 
 
5 ± 6 
- 3 ± 6 
1 ± 5 
 
4 ± 3 
-5 ± 5 
0 ± 6 
 
0.65 
0.68 
0.83 
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